通过生物物理和计算工具的特征,Isoguvacine在化后改善了其对白蛋白的结合特性
Yan Hong Ng1, Muhamad Imam Muhajir2, Rani Maharani2,3,4
1Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi, 43600, Selangor, Malaysia.
Scientific reports
|November 25, 2025
概括
新的前药物E7和E14显示改善了与人血清白蛋白 (HSA) 的结合,增强了治疗的异瓦辛 (IGV) 的输送. E14表现出优越的亲和力,表明了针对中枢神经系统的向治疗的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 影响着数以百万计的人,由于耐药性和副作用,需要除了当前的抗发作药物 (ASM) 之外的新疗法.
- 伊索古瓦辛 (IGV) 是一种GABA-A受体激动剂,显示出治疗前景,但其血脑屏障 (BBB) 穿透能力较差.
- 前药物E7和E14被合成,以改善BBB的透性和中枢神经系统 (CNS) 输送IGV.
研究的目的:
- 为了研究IGV,E7和E14与人血清白蛋白 (HSA) 之间的相互作用.
- 评估HSA结合如何影响这些潜在治疗药物的生物可用性和分布.
- 通过使用生物物理方法评估HSA在带结合后的结构完整性.
主要方法:
- 紫外线可见光谱检测,以确认蛋白质 - 配体复合.
- 异热定位热量计 (ITC) 用于量化结合亲缘关系.
- 原子力显微镜 (AFM) 和循环二元化 (CD) 光谱法用于评估结构变化.
- 分子对接和动力学模拟以预测结合模式和复杂稳定性.
主要成果:
- 紫外线光谱学证实了E7和E14与HSA的复杂化,与IGV相比,结合能力更强.
- ITC显示,与E7 (Ka = 3.41 × 10^4 M−1) 相比,对E14 (Ka = 2.42 × 10^6 M−1) 的结合亲和力显著高;IGV显示的相互作用是可以忽略不计的.
- AFM和CD表明,E7和E14结合稳定了HSA而不改变其二级或三级结构.
- 计算研究证实了E14的优越结合亲和力和E14-HSA复合物的稳定性.
结论:
- E14对HSA表现出优越的结合亲和力,这表明它是中枢神经系统向性治疗的有希望的前药物候选人.
- 提高E7和E14的疏水性促进了稳定的HSA相互作用,这对于调节药物输送至关重要.
- 了解白蛋白结合对于优化治疗中药物生物可用性和分布至关重要.
相关概念视频
Estimation of k and VD of Aminoglycosides
202
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
202
Hepatic Drug Clearance: Effect of Protein Binding
505
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
505
Protein-Drug Binding: Determination Methods
603
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
603
Drug Distribution: Plasma Protein Binding
8.3K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.3K
Protein-Drug Binding: Mechanism and Kinetics
1.6K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.6K


